Press Releases
Lotus Pharmaceuticals Announces Third Quarter Fiscal 2011 Financial Results 2011/11/11
Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 2011/08/15
Lotus Pharmaceuticals Announces First Quarter Fiscal 2011 Financial Results 2011/05/16
Lotus Pharmaceuticals Responds to Investor Concerns in Exclusive Interview 2011/04/25
Lotus Pharmaceuticals Announces Fiscal 2010 Financial Results 2011/03/28
Lotus Pharmaceuticals to Expand Construction of Beijing Facility 2011/02/04
Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government Split 2011/01/27
Lotus Pharmaceuticals Announces Fiscal 2010 Financial Results 2011/03/28
Lotus Pharmaceuticals Announces Approval of Reverse Stock Split 2010/12/31
Lotus Pharmaceuticals Announces Update on Land in Inner Mongolia Company to Sell or Transfer Land Parcel to Focus on Core Business in Beijing 2010/12/09
Lotus Pharmaceuticals Announces Participation in PHARMCHINA's 64th National Drug Fair Conference 2010/12/09
Lotus Pharmaceuticals Announces Third Quarter 2010 Financial Results 2010/11/11
Lotus Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2010 Financial Results 2010/11/10
Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical Trials of Asthma Drug R-Bambuterol 2010/10/27
Lotus Pharmaceuticals Preparing to Apply for National Exchange Listing 2010/10/22
Lotus Pharmaceuticals Announces New Patent for Controlled-Release Diabetes Drug 2010/10/19
Lotus Pharmaceuticals Retains Sichenzia Ross Friedman Ference LLP as General Legal Counsel 2010/10/06
Lotus Pharmaceuticals Announces Two Senior Management Appointments 2010/09/23
Lotus Pharmaceuticals Enter R-Bambuterol® Clinical Trial I 2010/08/26
Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 2010/08/16
Lotus Completed R-Bambuterol’s Pilot Scale Production for Clinical Trials 2010/08/03
Lotus Pharmaceuticals Terminates SEDA 2010/07/22
Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 2010/05/14
Lotus Pharmaceuticals’ Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials 2010/04/29
Lotus Pharmaceuticals’ Innovative Drug to Receive SFDA Fast Track Approval  2010/04/20
Lotus Pharmaceuticals, Inc. Reports Full Year 2009 Financial Results  2010/04/01
Lotus Pharmaceuticals Reports Groundbreaking Ceremony  2010/03/10
YA Global Master SPV Ltd Invests up to US$10,000,000 in Lotus Pharmaceutical, Inc. through Equity Line Facility  2010/03/03
Lotus Pharmaceuticals Announces New Prescription Drugs  2010/03/02
Lotus Pharmaceuticals to Commence Sarbanes-Oxley Compliance Project  2010/03/01
Lotus Pharmaceuticals Announces Key Changes   2010/01/15
Lotus Pharmaceuticals, Inc. Appoints OTC Division Head   2009/12/10
Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores  2009/11/30
Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA  2009/11/24
Lotus Pharmaceuticals,Inc. Reports Third-Quarter 2009 Results   2009/11/16
Lotus Pharmaceuticals,Inc. Announces Certain Clarification  2009/11/05
Lotus Pharmaceuticals, Inc. Announces 2010 Growth Strategy 2009/10/19
Lotus Reports Second Quarter 2009 Financial Results 2009/08/14
Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets 2009/07/30
Lotus Pharmaceuticals, Inc. Again Awarded GSP Certification 2009/06/29
Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 2009/05/18
Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 2009/04/22
Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug 2009/02/18
Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs  2009/02/05
Lotus Pharmaceuticals Announces Third Quarter 2008 Results 2008/11/18
Lotus Pharmaceuticals Announces Second Quarter 2008 Results 2008/08/18
Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008 2008/05/30
Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg 2008/04/24
Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 2008/04/17
Lotus Pharmaceuticals Raises $5 Million in Private Placement  2008/02/26
Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies  2008/02/07
Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets 2008/02/26
   
  Copyright © 2011 Lotus Pharmaceuticals, Inc. All Rights Reserved..
Home Contact